The Cathal Friel-backed European Green Transition venture has made its stock market debut on London’s Alternative Investment Market, raising £6.4m (€7.5m) before expenses from institutional investors and family offices.
EGT s breeding could not be better. It is from the stable of Cathal Friel, the entrepreneur who helped build and sell Amryt Pharma for just shy of $1.5 billion.